0001493152-18-003194.txt : 20180309 0001493152-18-003194.hdr.sgml : 20180309 20180309173246 ACCESSION NUMBER: 0001493152-18-003194 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180307 FILED AS OF DATE: 20180309 DATE AS OF CHANGE: 20180309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STOVER JACK E CENTRAL INDEX KEY: 0001203603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24249 FILM NUMBER: 18681279 MAIL ADDRESS: STREET 1: C/O SICOR INC STREET 2: 19 HUGHES CITY: IRVINE STATE: CA ZIP: 92618-1902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Interpace Diagnostics Group, Inc. CENTRAL INDEX KEY: 0001054102 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 222919486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING C, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 412-224-6100 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING C, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: PDI INC DATE OF NAME CHANGE: 20021113 FORMER COMPANY: FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC DATE OF NAME CHANGE: 19980129 4 1 form4.xml X0306 4 2018-03-07 0 0001054102 Interpace Diagnostics Group, Inc. IDXG 0001203603 STOVER JACK E C/O INTERPACE DIAGNOSTICS GROUP, INC. 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 1 1 0 0 President and CEO Common Stock 2018-03-07 4 A 0 56000 A 75738 D Stock Option (right to buy) 1.01 2018-03-07 4 A 0 224000 0.00 A 2028-03-07 Common Stock 224000 224000 D The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019. Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer"). Reflects 1-for-10 reverse stock split, effective as of December 28, 2016. The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer. /s/ Jack E. Stover 2018-03-09